51
Participants
Start Date
February 28, 2015
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2015
N91115
S Nitrosoglutathione Reductase Inhibitor
Columbia University, New York
The New York Presbyterian Hospital, Columbia University Medical Center, New York
Children's Hospital of Philadelphia, Philadelphia
Johns Hopkins Hospital, Baltimore
University of North Carolina, Chapel Hill
University of Alabama @ Birmingham, Birmingham
Nationwide Children's Hospital, Columbus
Rainbow Babies and Children's Hospital - Case Medical Center, Cleveland
Cincinnati Children's Hospital, Cincinnati
Indiana University, Indianapolis
University of Iowa Children's Hospital, Iowa City
University of Minnesota, Minneapolis
Northwestern University, Chicago
Washington University, St Louis
Children's CO, Aurora
National Jewish Health, Denver
Stanford University, Palo Alto
Seattle Children's Hospital, Seattle
Boston Children's Hospital, Boston
Lead Sponsor
Nivalis Therapeutics, Inc.
INDUSTRY